Chimerix, Inc. Profile Avatar - Palmy Investing

Chimerix, Inc.

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is …

Biotechnology
US, Durham [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Chimerix, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Chimerix, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Chimerix, Inc..

End of CMRX's Analysis
CIK: 1117480 CUSIP: 16934W106 ISIN: US16934W1062 LEI: - UEI: -
Secondary Listings
CMRX has no secondary listings inside our databases.